The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.
Source link
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
Date: